Finding patterns in lung cancer protein sequences for drug repurposing
PLOS One · 2025
DOI: 10.1371/journal.pone.0322546 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Belén Otero-Carrasco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Tecnología Biomédica, Universidad Politécnica de Madrid, Pozuelo de Alarcón, Madrid, Spain. Hauptthemen laut MEDLINE: Drug Repositioning, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Proteins are fundamental biomolecules composed of one or more chains of amino acids. They are essential for all living organisms, contributing to various biological functions and regulatory processes. Alterations in protein structures and functions are closely linked to diseases, emphasizing the need for in-depth study. A thorough understanding of these associations is crucial for developing targeted and more effective therapeutic strategies.Computational analyses of biomedical data facilitate the identification of specific patterns in proteins associated with diseases, providing novel insights into their biological roles. This study introduces a computational approach designed to detect relevant sequence patterns within proteins. These patterns, characterized by specific amino acid arrangements, can be critical for protein functionality. The proposed methodology was applied to proteins targeted by drugs used in lung cancer treatment, a disease that remains the leading cause of cancer-related mortality worldwide. Given that non-small cell lung cancer represents 85–90% of all lung cancer cases, it was selected as the primary focus of this study.Significant sequence patterns were identified, establishing connections between drug-target proteins and proteins associated with lung cancer. Based on these findings, a novel computational framework was developed to extend this pattern-based analysis to proteins linked to other diseases. By employing this approach, relationships between lung cancer drug-target proteins and proteins associated with four additional cancer types were uncovered. These associations, characterized by shared amino acid sequence features, suggest potential opportunities for drug repurposing. Furthermore, validation through an extensive literature review confirmed biological links between lung cancer drug-target proteins and proteins related to other malignancies, reinforcing the potential of this methodology for identifying new therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Tecnología Biomédica, Universidad Politécnica de Madrid, Pozuelo de Alarcón, Madrid, Spain.
- ETS Ingenieros Informáticos, Universidad Politécnica de Madrid, Boadilla del Monte, Madrid, Spain.
ORCID-Profile: Belén Otero-Carrasco, Gema Díaz Ferreiro, Juan Pedro Caraça-Valente Hernández
Förderung
- Ministerio de Ciencia e Innovación
Zitieren
APA
Otero-Carrasco, B., Nevado, P. T., Muñoz, R. A., Ferreiro, G. D., Pérez, A. P., Caraça-Valente Hernández, J. P., & Rodríguez-González, A. (2025). Finding patterns in lung cancer protein sequences for drug repurposing. PLOS One. https://doi.org/10.1371/journal.pone.0322546
Vancouver
Otero-Carrasco B, Nevado PT, Muñoz RA, Ferreiro GD, Pérez AP, Caraça-Valente Hernández JP, et al. Finding patterns in lung cancer protein sequences for drug repurposing. PLOS One. 2025. doi:10.1371/journal.pone.0322546
BibTeX
@article{OteroCarrasco2025,
author = {Otero-Carrasco, Belén and Nevado, Paloma Tejera and Muñoz, Rafael Artiñano and Ferreiro, Gema Díaz and Pérez, Aurora Pérez and Caraça-Valente Hernández, Juan Pedro and Rodríguez-González, Alejandro},
title = {Finding patterns in lung cancer protein sequences for drug repurposing},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0322546}
}
EUVIMED